From: Prevention and Management of Hepatitis B Virus Infection in Adults With HIV
This book is licensed under the terms of the Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0).
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Gupta A, Fine SM, Vail RM, et al. Prevention and Management of Hepatitis B Virus Infection in Adults With HIV [Internet]. Baltimore (MD): Johns Hopkins University; 2022 Aug.
In patients with positive anti-HBc, negative anti-HBs, and negative HBsAg test results, vaccinate with 1 standard dose of HBV vaccine and check anti-HBs titer after 8 weeks. If titer is <100 mlU/mL, complete remaining doses in the vaccine series and recheck titer 8 weeks after the last vaccine.
In patients with anti-HBs levels <10 mlU/mL (vaccine nonresponse), revaccination is recommended with the Heplisav-B vaccine series or a double dose of the vaccine series previously administered.
A patient who is negative for all serologies and who does not respond to revaccination may have a primary nonresponse or chronic infection. HBV DNA testing may be used to detect the presence of chronic HBV infection.
From: Prevention and Management of Hepatitis B Virus Infection in Adults With HIV
This book is licensed under the terms of the Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0).
Your browsing activity is empty.
Activity recording is turned off.
See more...